| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5571962 | Clinical Nutrition | 2017 | 33 Pages |
Abstract
Daily (2000Â IU/D) and monthly (40,000Â IU/month) vitD3 supplementation for six months in adults with DM and CKD was safe, and resulted in equivalent adherence and improvements in overall vitD status, but only modest changes in markers of bone health and QoL.
Keywords
vitDCholecalciferolN-telopeptide of type I collagenBMDQOLBTMNTXVitamin D3 supplementationpTHFGF-23SAEBSAPQuality of life1,25(OH)2D1,25-dihydroxyvitamin D25(OH)D25-hydroxyvitamin Dbone-specific alkaline phosphataseOsteocalcinDiabeteschronic kidney diseaseBone mineral densityBone healthadverse eventSerious adverse eventfibroblast growth factor 23Bone turnover markersCKDparathyroid hormoneinternational unitsVitamin D
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Diana R. Mager, Stephanie T. Jackson, Michelle R. Hoffmann, Kailash Jindal, Peter A. Senior,